Owlstonemedical

3 known investors

Owlstone Medical develops Breath Biopsy products and services that analyze volatile organic compounds from breath and other sample types to enable non-invasive diagnostic tests for early disease detection and precision medicine. It works across cancer, respiratory, gastrointestinal, microbiome, and liver disease, serving researchers and healthcare applications.